Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen
Science Immunology · 2026
DOI: 10.1126/sciimmunol.adk1673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Helen Stölting und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, UK. Hauptthemen laut MEDLINE: ErbB Receptors, Lung, Allergens, Th2 Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Wellcome, Asthma + Lung UK.
Abstract (Originalsprache)
Hormonal disruptions are associated with poor asthma control in females, yet how these phenomena are linked remains unknown. Here, we investigated distinct allergen-induced immune responses between the sexes during maturation. By 6 weeks of life, female mice exposed to the aeroallergen house dust mite (HDM) from postnatal day 7 exhibited stronger type 2 (T2) immune responses and higher lung interleukin-33 (IL-33) than males. IL-33 administration to HDM-sensitized males was sufficient to augment T2 immunity and up-regulated epidermal growth factor receptor (EGFR) on T helper 2 (T H 2) cells. EGFR inhibition abrogated T2 cytokine production in vitro. In vivo, EGFR inhibition reduced T2 immunity in females only, thereby abolishing any sex differences. 17β-estradiol (E 2 ) heightened lung Il33 expression and T2 responses of HDM-sensitized males, akin to levels in females. EGFR’s ability to drive sex differences in lung T2 responses downstream of E 2 and IL-33 may link hormonal disruptions to poor asthma control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Heart and Lung Institute, Imperial College London, London, UK.
- Centre for Paediatrics and Child Health, Imperial College London, London, UK.
ORCID-Profile: Helen Stölting, April L Raftery, Eimear N Rutherford, Mindy L Gore, Franz Puttur, Laura Yates, Sejal Saglani, Clare M Lloyd
Förderung
- Wellcome
- Asthma + Lung UK
Zitieren
APA
Stölting, H., Raftery, A. L., Walker, S. A., Rutherford, E. N., Gore, M. L., Huang, Y., Puttur, F., Yates, L., Saglani, S., & Lloyd, C. M. (2026). Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen. Science Immunology. https://doi.org/10.1126/sciimmunol.adk1673
Vancouver
Stölting H, Raftery AL, Walker SA, Rutherford EN, Gore ML, Huang Y, et al. Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen. Science Immunology. 2026. doi:10.1126/sciimmunol.adk1673
BibTeX
@article{Stlting2026,
author = {Stölting, Helen and Raftery, April L and Walker, Simone A and Rutherford, Eimear N and Gore, Mindy L and Huang, Yue and Puttur, Franz and Yates, Laura and Saglani, Sejal and Lloyd, Clare M},
title = {Epidermal growth factor receptor controls sex differences in lung type 2 responses to inhaled allergen},
journal = {Science Immunology},
year = {2026},
doi = {10.1126/sciimmunol.adk1673}
}
EUVIMED